Fully integrated. Completely automated. Entirely transformational.
Unrivaled diagnostic performance, today and into the future
The cobas® 6800 System can help you meet the growing needs of your lab with highly efficient workflows, from sample processing to result interpretation. Deliver trusted, reproducible results while rapidly completing your daily testing requirements.
Generate trusted, reproducible results with proven performace
Leverage absolute automation to drive increased effeciency
Deliver unmatched flexibility to meet your molecular testing demands - today and tomorrow
FIRST AND ONLY high volume fully automated system with a moderate complexity classification
Proven performance
Rapidly complete daily testing requirements
cobas 6800 system
8 hours workaway time*
Transform "walk-away" time into "work-away" time. Minimal and intuitive interactions reduce the potential for human error and free-up technicians for other tasks.
*May vary based on workflow demands.
Contamination prevention
Built in features to ensure the highest quality and integrity of patient results with no daily maintenance
Molecular testing - at any volume - in three easy steps
1. Load reagents & consumables
2. Load samples
3. Empty waste & review results
Unmatched flexibility
Flebible sample loading, processing, and testing
run IVDs and LDTs on a single system with the cobas omni Utility Channel
an expanded menu supports true test consolidation
lets the system do the work while staff performs critical tasks
supports continuous loading and the highest work-away time
and 3 tests simultaneously on up to 4 thermocyclers for ultimate testing flebibility
with 90-days stability
run the tests you want, when you want
the cobas 6800 System does it all for you
The cobas® 6800 System is designed to meet the ever-changing needs of your laboratory and your organization. The broad on-demand assay menu delivers reliable results across a wide range of applications, making test consolidation easy and effective.
Respiratory
SARS-CoV-2 (EUA) §+
(w/ Asymptomatic Claim & Patient Sample Pooling ||)
SARS-CoV-2 Variant (RUO)‡+
Cobas omni Utility Channel for third-party tests and LDTs
+ In development for use with cobas 5800
** Pending PMA approval for use with cobas 5800
*** Pending 510(k) clearance for use with cobas 5800
‡ For Life Science Research Use Only. Not for use in diagnostic procedures.
† This product is in development. This product is not available for use in the U.S.
* This test will be submitted to the FDA as a Master File and will not have a regulatory classification, and will not be cleared, licensed or approved by the FDA.
§ This test has not been FDA cleared or approved;
This test has been authorized by FDA under an EUA for use by authorized laboratories;
This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and
This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the authorization is terminated or revoked sooner
|| This workflow for the test has not been reviewed by the FDA. The test has been validated but FDA’s independent review of this validation is pending. This pooling workflow is distributed in accordance with Section IV.C of the FDA policy for Coronavirus Disease-2019 Tests during the Public Health Emergency (Revised) at https://www.fda.gov/media/135659.
Transforming testing and treatment together
Roche has been pioneering innovation in molecular testing for decades and remains committed to supporting laboratories in meeting both their own needs and the needs of the patients everywhere.
Speak with your Roche representative to learn more
cobas® 6800/8800 Systems Specifications Comparison
View Full Tablecobas® 6800/8800 Systems Specifications Comparison
Performance
| cobas® 6800 System | cobas® 8800 System | |
|---|---|---|
| Time to first results (up to 96 tests) | < 3.5 hours | |
| Subsequent batches (96 tests) | Every 90 minutes thereafter | Every 30 minutes thereafter |
| Maximum throughput * (8 hours)< |
384 | 1056 |
| Walk-away time * | 8 hours | 4 hours |
| Maximum number of tests per run | 96 tests, including controls | |
| Results released | Plates of up to 96 tests, with up to 3 assays per plate | |
| User interactions | 1. Load/unload samples, load reagents and consumables as needed 2. Remove waste (solid and liquid) 3. Review and release results |
|
Onboard inventory
| cobas® 6800 System | cobas® 8800 System | |
|---|---|---|
| Samples | 350 | |
| Assay reagent cassettes | Up to 12 | |
| Control cassettes | Up to 8 | |
| cobas omni MGP reagent | 2 | 4 |
| cobas omni specimen diluent reagent (1 L bottle) |
2 | 4 |
| cobas omni lysis reagent (1 L bottle) | 2 | 4 |
| cobas omni wash reagent (5 L bottle) | 3 | 6 |
| cobas omni processing plates | 8 | 16 |
| cobas omni amplification plates | 8 | 16 |
| cobas omni pipette tips | 8 | 16 |
Compatible tubes (both Systems)
| Tube size | Acceptable measurement (mm) |
|---|---|
| Height | 65–103 |
| Outside diameter (includes barcode label) | 12–16.2 |
Barcode types supported — both Systems (1–23 characters)
Power supply
| cobas® 6800 System | cobas® 8800 System | |
|---|---|---|
| Line voltage | 200–240 VAC +/- 10% | |
| Line frequency | 50/60 Hz +/- 5% | |
| Maximum power | 3500 VA | 8200 VA |
| Insulation coordination | Installation Category II (IEC 61010-1) |
|
Dimensions and weight
| cobas® 6800 System | cobas® 8800 System |
||
|---|---|---|---|
| Fixed | Moveable | ||
| Instrument dimension | 292 x 216 x 129 cm (W x H x D) |
292 x 222 x 129 cm (W x H x D) |
429 x 216 x 129 cm (W x H x D) |
| Instrument weight — Excluding instrument gateway server — Including instrument gateway server |
1573 kg 1624 kg |
1701 kg 1752 kg |
2354 kg 2405 kg |
Instrument gateway (both Systems)
Contamination prevention (both Systems)
Pre-analytic solutions
